BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9548446)

  • 41. Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis.
    Miskad UA; Semba S; Kato H; Yokozaki H
    Pathobiology; 2004; 71(4):176-84. PubMed ID: 15263806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Duodenal mucosa lactase, sucrase and alkaline phosphatase in 37 normal subjects in the Chongqing area].
    Lu ZA
    Zhonghua Yi Xue Za Zhi; 1989 Dec; 69(12):698-700. PubMed ID: 2517043
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of dietary sucrose on synthesis and degradation of intestinal sucrase.
    Riby JE; Kretchmer N
    Am J Physiol; 1984 Jun; 246(6 Pt 1):G757-63. PubMed ID: 6742126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
    Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
    Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
    Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
    Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mucin phenotypic expression and background mucosa of esophagogastric junctional adenocarcinoma.
    Tsuji N; Ishiguro S; Tsukamoto Y; Mano M; Kasugai T; Miyashiro I; Doki Y; Iishi H; Kudo M
    Gastric Cancer; 2004; 7(2):97-103. PubMed ID: 15224196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Special features of intestinal metaplasia and its relation to early gastric carcinoma in man: observation by a method in which leucine aminopeptidase activity is used.
    Nakahara K
    J Natl Cancer Inst; 1978 Sep; 61(3):693-701. PubMed ID: 278846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Precancerous changes in the stomach.
    Kawachi T; Kurisu M; Numanyu N; Sasajima K; Sano T
    Cancer Res; 1976 Jul; 36(7 PT 2):2673-7. PubMed ID: 58722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinoma.
    Nakamura T; Yao T; Kabashima A; Nishiyama K; Maehara Y; Tsuneyoshi M
    Histopathology; 2005 Oct; 47(4):357-67. PubMed ID: 16178890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overexpression of cyclin-dependent kinase-activating CDC25B phosphatase in human gastric carcinomas.
    Kudo Y; Yasui W; Ue T; Yamamoto S; Yokozaki H; Nikai H; Tahara E
    Jpn J Cancer Res; 1997 Oct; 88(10):947-52. PubMed ID: 9414655
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma.
    Zheng HC; Zheng YS; Li XH; Takahashi H; Hara T; Masuda S; Yang XH; Guan YF; Takano Y
    Anticancer Res; 2008; 28(4B):2225-32. PubMed ID: 18751399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blood group activity of human sucrase from intestinal metaplasia.
    Kurisu M; Numanyu N; Kawachi T; Sugimura T
    J Biol Chem; 1977 May; 252(10):3277-80. PubMed ID: 68034
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression.
    Koseki K; Takizawa T; Koike M; Ito M; Nihei Z; Sugihara K
    Cancer; 2000 Aug; 89(4):724-32. PubMed ID: 10951333
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma.
    Saukkonen K; Nieminen O; van Rees B; Vilkki S; Härkönen M; Juhola M; Mecklin JP; Sipponen P; Ristimäki A
    Clin Cancer Res; 2001 Jul; 7(7):1923-31. PubMed ID: 11448905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intestinal metaplasia of the stomach as a precancerous stage.
    Sugimura T; Matsukura N; Sato S
    IARC Sci Publ; 1982; (39):515-30. PubMed ID: 6759388
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemical staining for P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha may complement mucin phenotype of differentiated-type early gastric carcinoma.
    Takano K; Hasegawa G; Jiang S; Kurosaki I; Hatakeyama K; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
    Pathol Int; 2009 Jul; 59(7):462-70. PubMed ID: 19563409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. COL4A3 expression correlates with pathogenesis, pathologic behaviors, and prognosis of gastric carcinomas.
    Nie XC; Wang JP; Zhu W; Xu XY; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
    Hum Pathol; 2013 Jan; 44(1):77-86. PubMed ID: 22939955
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions.
    Tajima Y; Shimoda T; Nakanishi Y; Yokoyama N; Tanaka T; Shimizu K; Saito T; Kawamura M; Kusano M; Kumagai K
    Oncology; 2001; 61(3):212-20. PubMed ID: 11574777
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of a hybrid form of alkaline phosphatase isoenzyme in a newly established cell line (HuG-1) from a gastric cancer patient.
    Imanishi H; Hada T; Muratani K; Hirano K; Higashino K
    Cancer Res; 1990 Jun; 50(11):3408-12. PubMed ID: 2334935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines.
    van Rees BP; Sivula A; Thorén S; Yokozaki H; Jakobsson PJ; Offerhaus GJ; Ristimäki A
    Int J Cancer; 2003 Nov; 107(4):551-6. PubMed ID: 14520691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.